Abstract
In this review we describe in detail the available technologies used for investigating the substrate specificity of proteases. Critical comparison of the available detection methods and their choice for certain type of screening is discussed. We present successful strategies along with appropriate examples for the design and synthesis of combinatorial libraries of substrates using both chemical and biological approaches. Proteomic tools for the identification of natural substrates of proteases are also discussed.
Keywords: Protease, substrate, library, fluorogenic, substrate specificity, combinatorial, positional scanning substrate combinatorial library, MEROPS, Activity Based Probes, ABPs, AMC, 7-amino-4-methylcoumarin, AFC, 7-amino-4-trifluoromethylcoumarin, ACC, 7-amino-4-carbamoylmethylcoumarin, 6-amino-1-naphtalenesulfonamide, ANSN, substrate activity screening, SAS, N-acyl-7-amino-4-methylcoumarin acetic acid, AMCA, p-nitroanilide, pNA, 5-fluorosalicylic acid, fsa, Tb(EDTA), rhodesain, Trypanasoma brucei, quencher, Leishmania mexicana, stromelysin, matrilysin, collagenase-3, MMP-2, MT1-MMP, furin, thrombin, granzyme B, PROTOMAP, iTRAQ, iCat, PICS, Proteomic Identification of protease Cleavage Sites, serine proteases, aspartic proteases, cysteine proteases
Current Medicinal Chemistry
Title: Current Strategies for Probing Substrate Specificity of Proteases
Volume: 17 Issue: 33
Author(s): M. Poreba and M. Drag
Affiliation:
Keywords: Protease, substrate, library, fluorogenic, substrate specificity, combinatorial, positional scanning substrate combinatorial library, MEROPS, Activity Based Probes, ABPs, AMC, 7-amino-4-methylcoumarin, AFC, 7-amino-4-trifluoromethylcoumarin, ACC, 7-amino-4-carbamoylmethylcoumarin, 6-amino-1-naphtalenesulfonamide, ANSN, substrate activity screening, SAS, N-acyl-7-amino-4-methylcoumarin acetic acid, AMCA, p-nitroanilide, pNA, 5-fluorosalicylic acid, fsa, Tb(EDTA), rhodesain, Trypanasoma brucei, quencher, Leishmania mexicana, stromelysin, matrilysin, collagenase-3, MMP-2, MT1-MMP, furin, thrombin, granzyme B, PROTOMAP, iTRAQ, iCat, PICS, Proteomic Identification of protease Cleavage Sites, serine proteases, aspartic proteases, cysteine proteases
Abstract: In this review we describe in detail the available technologies used for investigating the substrate specificity of proteases. Critical comparison of the available detection methods and their choice for certain type of screening is discussed. We present successful strategies along with appropriate examples for the design and synthesis of combinatorial libraries of substrates using both chemical and biological approaches. Proteomic tools for the identification of natural substrates of proteases are also discussed.
Export Options
About this article
Cite this article as:
Poreba M. and Drag M., Current Strategies for Probing Substrate Specificity of Proteases, Current Medicinal Chemistry 2010; 17 (33) . https://dx.doi.org/10.2174/092986710793205381
DOI https://dx.doi.org/10.2174/092986710793205381 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Color-Coded Fluorescent Protein Imaging of Angiogenesis: The AngioMouse® Models
Current Pharmaceutical Design mTOR Inhibitors: Facing New Challenges Ahead
Current Medicinal Chemistry Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors
Current Medicinal Chemistry Immunology Behind Tumors: A Mini Review
Current Cancer Therapy Reviews Cytochrome P450-Activated Prodrugs: Targeted Drug Delivery
Current Medicinal Chemistry Pathogenesis of HIV-Associated Non-Hodgkin Lymphoma
Current HIV Research Roles of Laminin-332 and α6β4 Integrin in Tumor Progression
Mini-Reviews in Medicinal Chemistry Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones
Current Medicinal Chemistry Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here
Current Drug Metabolism Therapeutic Use of Chemokines
Current Pharmaceutical Design Developments of Combretastatin A-4 Derivatives as Anticancer Agents
Current Medicinal Chemistry Non-squamous Tumors of the Oropharynx and Oral Cavity: CT and MR Imaging Findings with Clinical- Pathologic Correlation
Current Medical Imaging Novel Insights Into the Role of MicroRNA in Lung Cancer Resistance to Treatment and Targeted Therapy
Current Cancer Drug Targets RETRACTED: Novel and safer self-inactivating vectors for gene therapy of Wiskott-Aldrich Syndrome
Current Gene Therapy Systematic Evaluation of Drug-Loaded Hydrogels for Application in Osteosarcoma Treatment
Current Pharmaceutical Biotechnology Aspartic Protease Inhibitors as Potential Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and Pathogenesis
Current Medicinal Chemistry Physiologically Based Pharmacokinetic Models: Integration of In Silico Approaches with Micro Cell Culture Analogues
Current Drug Metabolism The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer
Current Pharmaceutical Design Green Approaches for Cancers Management: An Effective Tool for Health Care
Anti-Cancer Agents in Medicinal Chemistry Deubiquitinating Enzymes as Promising Drug Targets for Infectious Diseases
Current Pharmaceutical Design